Cognition Therapeutics Correlations

CGTX Stock

USD 0.40 0.01 2.44%

The current 90-days correlation between Cognition Therapeutics and Eyenovia is 0.36 (i.e., Weak diversification). The correlation of Cognition Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cognition Therapeutics Correlation With Market

Average diversification

The correlation between Cognition Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.

Moving together with Cognition Stock

0.68	INAB	In8bio Inc	Pair Corr
0.7	INMB	INmune Bio	Pair Corr
0.74	REVB	Revelation Biosciences	Pair Corr
0.74	SIGA	SIGA Technologies	Pair Corr

Moving against Cognition Stock

0.62	BHC	Bausch Health Companies	Pair Corr
0.57	EWTX	Edgewise Therapeutics	Pair Corr
0.55	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.49	WAT	Waters	Pair Corr
0.45	GILD	Gilead Sciences	Pair Corr
0.44	GANX	Gain Therapeutics	Pair Corr
0.42	ESPR	Esperion Therapeutics	Pair Corr
0.4	HCM	HUTCHMED DRC	Pair Corr
0.38	BCTXW	BriaCell Therapeutics	Pair Corr
0.62	BSX	Boston Scientific Corp	Pair Corr
0.55	CVS	CVS Health Corp Aggressive Push	Pair Corr

Related Correlations Analysis

	RVPHW	EYEN	RNAZ	KOD	TFFP	TCRX	CUE	DRMA	GANX	LIFE
RVPHW		-0.6	-0.31	0.37	-0.61	-0.48	-0.3	-0.26	-0.32	-0.15	RVPHW
EYEN	-0.6		0.19	-0.77	0.94	0.74	-0.06	0.6	0.11	0.35	EYEN
RNAZ	-0.31	0.19		-0.09	0.29	-0.09	0.44	-0.22	0.78	-0.14	RNAZ
KOD	0.37	-0.77	-0.09		-0.78	-0.64	0.54	-0.67	0.25	-0.31	KOD
TFFP	-0.61	0.94	0.29	-0.78		0.64	-0.05	0.6	0.18	0.3	TFFP
TCRX	-0.48	0.74	-0.09	-0.64	0.64		-0.2	0.56	-0.18	0.2	TCRX
CUE	-0.3	-0.06	0.44	0.54	-0.05	-0.2		-0.55	0.76	-0.12	CUE
DRMA	-0.26	0.6	-0.22	-0.67	0.6	0.56	-0.55		-0.33	0.27	DRMA
GANX	-0.32	0.11	0.78	0.25	0.18	-0.18	0.76	-0.33		-0.12	GANX
LIFE	-0.15	0.35	-0.14	-0.31	0.3	0.2	-0.12	0.27	-0.12		LIFE
	RVPHW	EYEN	RNAZ	KOD	TFFP	TCRX	CUE	DRMA	GANX	LIFE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TFFP	+ 0.94	EYEN
GANX	+ 0.78	RNAZ
GANX	+ 0.76	CUE
TCRX	+ 0.74	EYEN
TCRX	+ 0.64	TFFP
DRMA	+ 0.6	EYEN

High negative correlations

TFFP	- 0.78	KOD
KOD	- 0.77	EYEN
DRMA	- 0.67	KOD
TCRX	- 0.64	KOD
TFFP	- 0.61	RVPHW
EYEN	- 0.6	RVPHW

Risk-Adjusted Indicators

There is a big difference between Cognition Stock performing well and Cognition Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cognition Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RVPHW	14.04	3.14	0.16	(10.37)	15.23	(17.56)	28.57	(22.22)	129.53
EYEN	6.65	(1.97)	0.00	(0.53)	0.00	0.00	14.29	(19.18)	92.81
RNAZ	8.23	1.11	0.10	(0.56)	7.15	(11.79)	22.00	(11.54)	68.80
KOD	3.15	1.20	0.44	0.65	2.23	(4.28)	9.70	(4.87)	18.79
TFFP	6.89	(1.75)	0.00	(1.33)	0.00	0.00	11.28	(12.99)	95.77
TCRX	2.84	(0.44)	0.00	(0.07)	0.00	0.00	6.10	(5.05)	17.54
CUE	7.68	1.25	0.19	1.35	5.91	(11.91)	20.27	(11.51)	67.78
DRMA	4.89	(0.60)	0.00	(0.24)	0.00	0.00	9.22	(8.05)	69.06
GANX	5.54	0.58	0.08	0.65	6.39	(6.60)	14.68	(10.78)	36.84
LIFE	2.57	0.38	0.09	2.06	2.62	(3.23)	6.45	(5.29)	28.98

Cognition Therapeutics Corporate Management

Steven Weissman	VP CMC	Profile
Bobby Horn	Corporate Controller	Profile
Andrew CPA	Interim Officer	Profile
John Doyle	Chief Officer	Profile
Anita Cornet	Head Quality	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC